The combination of anti-HBc and anti-HBs levels is a useful predictor of the development of chemotherapy-induced reactivation in lymphoma patients with resolved HBV infection

Fatal chemotherapy-induced hepatitis B virus reactivation (HBV-R) is a well-described serious complication observed in patients with lymphoma and resolved HBV infection. The aim of the present study was to determine the predictive factors of the development of chemotherapy-induced HBV-R. A total of...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsubara, Tokuhiro, Nishida, Tsutomu, Shimoda, Akiyoshi, Shimakoshi, Hiromi, Amano, Takahiro, Sugimoto, Aya, Takahashi, Kei, Mukai, Kaori, Yamamoto, Masashi, Hayashi, Shiro, Nakajima, Sachiko, Fukui, Koji, Inada, Masami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680641/
https://www.ncbi.nlm.nih.gov/pubmed/29151907
http://dx.doi.org/10.3892/ol.2017.7012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680641/
https://www.ncbi.nlm.nih.gov/pubmed/29151907
http://dx.doi.org/10.3892/ol.2017.7012

Ejemplares similares